methyl (2E,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-4-((1R,2S,4S)-4-{[tert-butyl(dimethyl)-silyl]oxy}-2-{(1E)-7,7,7-trifluoro-6-[(triethylsilyl)oxy]hept-1-en-1-yl}cyclopentyl)but-2-enoate

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: methyl (2E,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-4-((1R,2S,4S)-4-{[tert-butyl(dimethyl)-silyl]oxy}-2-{(1E)-7,7,7-trifluoro-6-[(triethylsilyl)oxy]hept-1-en-1-yl}cyclopentyl)but-2-enoate
• 英文别名: methyl (E,4R)-4-[tert-butyl(dimethyl)silyl]oxy-4-[(1R,2S,4S)-4-[tert-butyl(dimethyl)silyl]oxy-2-[(E)-7,7,7-trifluoro-6-triethylsilyloxyhept-1-enyl]cyclopentyl]but-2-enoate
• 化学式: C₃₅H₆₇F₃O₅Si₃
• 分子量: 709.166
• InChiKey: JYJAWEAUXQSAIO-AGUQZTJRSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  11.2
• 重原子数：
  46
• 可旋转键数：
  20
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  54
• 氢给体数：
  0
• 氢受体数：
  8

反应信息

• 作为反应物：
  描述：

  methyl (2E,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-4-((1R,2S,4S)-4-{[tert-butyl(dimethyl)-silyl]oxy}-2-{(1E)-7,7,7-trifluoro-6-[(triethylsilyl)oxy]hept-1-en-1-yl}cyclopentyl)but-2-enoate 在 甲醇 、 2,4,6-三氯苯甲酰氯 、 triethylamine tris(hydrogen fluoride) 、 三乙胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 乙腈 为溶剂， 反应 19.5h， 生成 methyl (2E,4R)-4-{[tert-Butyl(dimethyl)silyl]oxy}-4-{(1R,2S,4S)-4-{[tert-butyl(dimethyl)-silyl]oxy}-2-[(1E)-7,7,7-trifluoro-6-hydroxyhept-1-en-1-yl]cyclopentyl}but-2-enoate
  参考文献：
  名称：

  Synthesis and Biological Properties of Novel Brefeldin A Analogues

  摘要：

  New brefeldin A (1) analogues were obtained by introducing a variety of substituents at C15. Most of the analogues exhibited significant biological activity. (15R)-Trifluoromethyl-nor-brefeldin A (3), (15R)-vinyl-nor-brefeldin A (5), their epimers 4 and 6 as well as (15S)-ethyl-nor-brefeldin A (2) were prepared from the key building blocks 12 or 24 by Julia-Kocienski olefination with tetrazolyl sulfones and subsequent macrolactonization. The vinyl derivative 5 allowed analogues to be synthesized by hydroboration and Suzuki-Miyaura coupling. The following biological properties were assessed: (a) inhibition of cell growth of human cancer cells (NCI), (b) induction of morphological changes of the Golgi apparatus of plant and mammalian cells, and (c) influence on the replication of the enterovirus CVB3. Furthermore, conformational aspects were studied by X-ray crystal structure analysis and molecular mechanics calculations, including docking of the analogues into the brefeldin A binding site of an Arf1/Sec7-complex.

  DOI：

  10.1021/jm400615g
• 作为产物：
  描述：

  布雷非德菌素 A 在 咪唑 、 4-二甲氨基吡啶 、 potassium osmate(VI) dihydrate 、 sodium periodate 、 双(三甲基硅烷基)氨基钾 、 N-甲基吗啉氧化物 、 potassium hydroxide 作用下， 以 四氢呋喃 、 甲醇 、 乙二醇二甲醚 、 二氯甲烷 、 水 、 丙酮 、 甲苯 为溶剂， 反应 21.5h， 生成 methyl (2E,4R)-4-{[tert-butyl(dimethyl)silyl]oxy}-4-((1R,2S,4S)-4-{[tert-butyl(dimethyl)-silyl]oxy}-2-{(1E)-7,7,7-trifluoro-6-[(triethylsilyl)oxy]hept-1-en-1-yl}cyclopentyl)but-2-enoate
  参考文献：
  名称：

  Synthesis and Biological Properties of Novel Brefeldin A Analogues

  摘要：

  New brefeldin A (1) analogues were obtained by introducing a variety of substituents at C15. Most of the analogues exhibited significant biological activity. (15R)-Trifluoromethyl-nor-brefeldin A (3), (15R)-vinyl-nor-brefeldin A (5), their epimers 4 and 6 as well as (15S)-ethyl-nor-brefeldin A (2) were prepared from the key building blocks 12 or 24 by Julia-Kocienski olefination with tetrazolyl sulfones and subsequent macrolactonization. The vinyl derivative 5 allowed analogues to be synthesized by hydroboration and Suzuki-Miyaura coupling. The following biological properties were assessed: (a) inhibition of cell growth of human cancer cells (NCI), (b) induction of morphological changes of the Golgi apparatus of plant and mammalian cells, and (c) influence on the replication of the enterovirus CVB3. Furthermore, conformational aspects were studied by X-ray crystal structure analysis and molecular mechanics calculations, including docking of the analogues into the brefeldin A binding site of an Arf1/Sec7-complex.

  DOI：

  10.1021/jm400615g